New clinical research bolsters the bimodal-balance recovery theory of rehabilitation for post-stroke unilateral upper limb paresis. The implications hold promise for tailoring brain stimulation protocols.
This livestreamed CME conference will help equip healthcare professionals to be part of the solution for addressing healthcare disparities surrounding stroke, heart attack and more.
To mitigate the risk of a cerebrovascular accident from cardiac surgery for endocarditis, Cleveland Clinic takes care to routinely image the brain and include a stroke specialist in the preoperative evaluation.
Hospital transfer for acute ischemic stroke is linked to poorer outcomes, and the AHA’s Target: Stroke initiative has trimmed time to thrombolytic therapy and lowered one-year readmissions. So conclude two new national database analyses.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
The director of our Mobile Stroke Treatment Unit reflects on lessons from our first six years of experience, along with what’s on the horizon in mobile stroke care.
Changes around stroke center designation, rural stroke care, telestroke services and reimbursement are highlights of the American Academy of Neurology’s first statement update in 10 years.
The first-ever expert statement on reducing perioperative stroke risk in this setting underscores the imperative for a team strategy bringing multidisciplinary expertise to bear.
The 3,000-patient PROTECTED TAVR trial is large enough to detect a clinical reduction in stroke at 72 hours. And the ongoing WATCH-TAVR trial aims to show whether simultaneous TAVR and Watchman placement is safe and cost-saving.
A multicenter group of stroke experts has published guidance for optimizing care for virus-infected individuals while maintaining ideal stroke management and protecting stroke clinicians.
An NIH grant will help Cleveland Clinic researchers determine whether the novel dual-action agent can safely lengthen the thrombolytic time window in ischemic stroke and protect against reperfusion injury.